<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>North Bay Business Journal &#187; Todd Zankel</title>
	<atom:link href="http://www.northbaybusinessjournal.com/tag/todd-zankel/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.northbaybusinessjournal.com</link>
	<description></description>
	<lastBuildDate>Thu, 09 Feb 2012 02:43:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Novato’s Raptor has promising breast cancer inhibitor</title>
		<link>http://www.northbaybusinessjournal.com/19294/novatos-raptor-has-promising-breast-cancer-inhibitor/</link>
		<comments>http://www.northbaybusinessjournal.com/19294/novatos-raptor-has-promising-breast-cancer-inhibitor/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 11:45:00 +0000</pubDate>
		<dc:creator>Loralee Stevens, Business Journal Staff Reporter</dc:creator>
				<category><![CDATA[Health Care and Senior Living]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Top News Stories]]></category>
		<category><![CDATA[Christopher Starr]]></category>
		<category><![CDATA[Guojun Bu]]></category>
		<category><![CDATA[LRP6]]></category>
		<category><![CDATA[Marin County]]></category>
		<category><![CDATA[Novato]]></category>
		<category><![CDATA[Raptor Pharmaceutical]]></category>
		<category><![CDATA[Todd Zankel]]></category>
		<category><![CDATA[triple negative breast cancer]]></category>

		<guid isPermaLink="false">http://www.northbaybusinessjournal.com/?p=19294</guid>
		<description><![CDATA[NOVATO -- A peptide acquired by Raptor Pharmaceutical Corp. as a possible delivery system for drug therapies has shown itself to be a direct inhibitor of the protein necessary for the growth of a particularly hard-to-treat form of breast cancer.]]></description>
		<wfw:commentRss>http://www.northbaybusinessjournal.com/19294/novatos-raptor-has-promising-breast-cancer-inhibitor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

